Loading...

ANAB ANAPTYSBIO INC Earnings Reports 8-K Filing

NPTY

NB

ANAPTYSBIO INC

(ANAB)

2026 8-K

Major Spin-Off Announcement

Financial Results Announced

Financial Update

Legal Dispute Filed

Stock Repurchase Update

Legal Dispute Filing

Investor Update

Financial Results

Investor Presentation Update

Business Separation Plans

Product Expansion

Financial Statements

Stock Repurchase

Financial Results

Investor Presentation

Clinical Trial Results

License Agreement

Financial Results

Financial Results Announcement

Annual Meeting of Stockholders

Earnings Reports

Financial Results Announcement

Financial Information Prese...

License Agreement with Cent...

Earnings Report

Clinical Trial Results

Management Changes

Financial Results Announcement

Annual Meeting of Stockholders

Earnings Report

Resignation and Appointment...

Financial Results Announcement

Amendment to Bylaws

Stock Repurchase Plan

Financial Update

External Links:

On January 11, 2026, AnaptysBio, Inc. will disclose preliminary financial data, indicating about $310 million in cash and investments as of December 31, 2025. The data is subject to change pending the audit of financial statements.

AI Assistant

ANAPTYSBIO INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.